<p>Today’s episode features a conversation with Dr. Tatiana Novobrantseva, Co-Founder and CSO of Verseau Therapeutics.  In this interview, we discuss five trends in the development of cancer immunotherapies and how these will impact patients and biopharmaceutical research and development.</p>

Today’s episode features a conversation with Dr. Tatiana Novobrantseva, Co-Founder and CSO of Verseau Therapeutics. In this interview, we discuss five trends in the development of cancer immunotherapies and how these will impact patients and biopharmaceutical research and development.

<p>Today’s episode features a conversation with Dr. Tatiana Novobrantseva, Co-Founder and CSO of Verseau Therapeutics.&nbsp; In this interview, we discuss five trends in the development of cancer immunotherapies and how these will impact patients and biopharmaceutical research and development.</p>

Episode 15: Cancer Immunotherapy Trends to Impact Patients and R&D

The Chain explores the lives, careers, research, and discoveries of protein engineers and scientists, the impact their work is having on the field, and where the industry is headed. Tune in to stay up-to-date on the newest advancements and to hear the stories that are impacting the world of biologics.

Share Episode 15: Cancer Immunotherapy Trends to Impact Patients and R&D

Sign up to save your podcasts

Episode 15: Cancer Immunotherapy Trends to Impact Patients and R&D

Episode 15: Cancer Immunotherapy Trends to Impact Patients and R&D

More shows like The Chain: Protein Engineering Podcast

The Book Review

Nature Podcast

The Daily

The Long Run with Luke Timmerman

Today, Explained

The Readout Loud

The Journal.

All-In with Chamath, Jason, Sacks & Friedberg

BioCentury This Week

Biotech Hangout

ZOE Science & Nutrition